Related Experiment Video
Updated: Feb 11, 2026

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
Published on: November 25, 2022
Inhibition of Human Amylin Aggregation and Cellular Toxicity by Lipoic Acid and Ascorbic Acid
Sarah Kassem Azzam1, Hyunwoo Jang2, Myung Chul Choi2
1Department of Biomedical Engineering , Khalifa University of Science and Technology , P.O. Box 127788, Abu Dhabi , United Arab Emirates.
Abstract:
More than 30 human degenerative diseases result from protein aggregation such as Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM). Islet amyloid deposits, a hallmark in T2DM, are found in pancreatic islets of more than 90% of T2DM patients. An association between amylin aggregation and reduction in β-cell mass was also established by post-mortem studies. A strategy in preventing protein aggregation-related disorders is to inhibit the protein aggregation and associated toxicity. In this study, we demonstrated that two inhibitors, lipoic acid and ascorbic acid, significantly inhibited amylin aggregation. Compared to amylin (15 μM) as 100%, lipoic acid and ascorbic acid reduced amylin fibril formation to 42.1 ± 17.2% and 42.9 ± 12.8%, respectively, which is confirmed by fluorescence and TEM images. In cell viability tests, both inhibitors protected RIN-m5f β-cells from the toxicity of amylin aggregates. At 10:1 molar ratio of lipoic acid to amylin, lipoic acid with amylin increased the cell viability to 70.3%, whereas only 42.8% RIN-m5f β-cells survived in amylin aggregates. For ascorbic acid, an equimolar ratio achieved the highest cell viability of 63.3% as compared to 42.8% with amylin aggregates only. Docking results showed that lipoic acid and ascorbic acid physically interact with amylin amyloidogenic region (residues Ser20-Ser29) via hydrophobic interactions; hence reducing aggregation levels. Therefore, lipoic acid and ascorbic acid prevented amylin aggregation via hydrophobic interactions, which resulted in the prevention of cell toxicity in vitro.
Insights
Lipoic acid and ascorbic acid inhibit amylin aggregation, a key factor in type 2 diabetes mellitus (T2DM). These antioxidants protect pancreatic beta cells from toxic amylin aggregates, offering a potential therapeutic strategy for T2DM.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Medicine
Background:
- Protein aggregation, implicated in over 30 degenerative diseases like Alzheimer's and type 2 diabetes mellitus (T2DM), involves islet amyloid deposits in T2DM.
- Amylin aggregation is linked to reduced pancreatic beta-cell mass, a critical factor in T2DM pathogenesis.
Purpose of the Study:
- To investigate the inhibitory effects of lipoic acid and ascorbic acid on amylin aggregation and subsequent beta-cell toxicity.
- To elucidate the molecular mechanisms underlying the interaction between these inhibitors and amylin.
Main Methods:
- Amylin aggregation inhibition was quantified using fluorescence assays and transmission electron microscopy (TEM).
- Cell viability assays (RIN-m5f beta-cells) assessed the protective effects of inhibitors against amylin aggregate toxicity.
- Molecular docking simulations were employed to analyze the binding interactions between inhibitors and amylin.
Main Results:
- Lipoic acid and ascorbic acid significantly reduced amylin fibril formation to 42.1% and 42.9% respectively.
- Both inhibitors demonstrated protective effects on beta-cells, increasing cell viability from 42.8% to 70.3% (lipoic acid) and 63.3% (ascorbic acid).
- Docking studies revealed hydrophobic interactions between the inhibitors and the amylin amyloidogenic region (Ser20-Ser29).
Conclusions:
- Lipoic acid and ascorbic acid effectively inhibit amylin aggregation through hydrophobic interactions.
- These compounds mitigate the cytotoxic effects of amylin aggregates on pancreatic beta-cells in vitro.
- The findings suggest a potential therapeutic role for lipoic acid and ascorbic acid in managing T2DM by preventing amylin-related beta-cell dysfunction.
Related Concept Videos
Polyprotic Acids
Amino acids
Mixtures of Acids
A Mixture of a Strong Acid and a Weak Acid
In a mixture of a strong acid and a weak acid, the strong acid dissociates completely and becomes a source of almost all the hydronium ions...
Nucleic Acids
DNA and RNA
The two main types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and in the organelles, chloroplasts, and mitochondria. In prokaryotes,...
Nucleic acids
DNA and RNA
The two main types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and in the organelles, chloroplasts, and mitochondria. In prokaryotes,...
Acidity of Carboxylic Acids

